Previous Close | 135.40 |
Open | 134.70 |
Bid | 135.80 x 0 |
Ask | 136.10 x 0 |
Day's Range | 134.10 - 136.40 |
52 Week Range | 79.25 - 169.80 |
Volume | |
Avg. Volume | 108,626 |
Market Cap | 16.574B |
Beta (5Y Monthly) | 1.26 |
PE Ratio (TTM) | 140.21 |
EPS (TTM) | 0.97 |
Earnings Date | Oct 23, 2024 |
Forward Dividend & Yield | 0.50 (0.37%) |
Ex-Dividend Date | May 15, 2024 |
1y Target Est | 167.75 |
Despite stable organic growth and strategic acquisitions, AddLife AB faces market hesitancies and regional disruptions impacting performance.
AddLife AB (FRA:1AD1) reports robust revenue and EBITDA growth, with strategic acquisitions enhancing its market position despite ongoing challenges.
As global markets show signs of recovery, with small-cap stocks like the Russell 2000 Index recently outperforming their larger counterparts, investors may find potential opportunities in undervalued small caps. In this context, understanding insider actions can provide valuable insights into promising stocks that might be overlooked by the broader market.